93 related articles for article (PubMed ID: 6393610)
21. Serological responses in Lyme disease: the influence of sex, age, and environment.
Fidelus-Gort R; Gilmour RW; Kashatus WC
Ann Clin Lab Sci; 1993; 23(3):221-9. PubMed ID: 8323257
[TBL] [Abstract][Full Text] [Related]
22. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
[TBL] [Abstract][Full Text] [Related]
23. Chronic meningitis and Lyme disease in Sweden.
Stiernstedt GT; Sköldenberg BR; Vandvik B; Hederstedt B; Gårde A; Kolmodin G; Jörbäck H; Svenungsson B
Yale J Biol Med; 1984; 57(4):491-7. PubMed ID: 6516451
[TBL] [Abstract][Full Text] [Related]
24. [Isolation of the recombinant proteins OspC and the fragment FlaA (F-FLAA) from the western-Siberian Borrelia garinii NT29 isolates and the study of their immunochemical properties].
Karavaev VS; Ivanov ID; Riabchenko AV; Beklemishev AB
Mol Gen Mikrobiol Virusol; 2008; (1):18-22. PubMed ID: 18368777
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
26. Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete.
Barbour AG; Burgdorfer W; Grunwaldt E; Steere AC
J Clin Invest; 1983 Aug; 72(2):504-15. PubMed ID: 6348092
[TBL] [Abstract][Full Text] [Related]
27. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
28. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
[TBL] [Abstract][Full Text] [Related]
29. Cross-reaction between Yersinia outer membrane proteins and anti-Borrelia antibodies in sera of patients with Lyme disease.
Golkocheva-Markova E; Christova I; Stoilov R; Najdenski H
Clin Microbiol Infect; 2008 Sep; 14(9):873-5. PubMed ID: 18844689
[TBL] [Abstract][Full Text] [Related]
30. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
[No Abstract] [Full Text] [Related]
31. Serological tests for Lyme disease in patients with tropical spastic paraparesis and healthy Jamaicans.
Smikle MF; Morgan OS; Barton EN; Bailey V; Blattner WA
Trop Geogr Med; 1994; 46(5):329-30. PubMed ID: 7855925
[TBL] [Abstract][Full Text] [Related]
32. Human phagocyte interactions with the Lyme disease spirochete.
Peterson PK; Clawson CC; Lee DA; Garlich DJ; Quie PG; Johnson RC
Infect Immun; 1984 Nov; 46(2):608-11. PubMed ID: 6500703
[TBL] [Abstract][Full Text] [Related]
33. Serological diagnosis of erythema migrans disease and related disorders.
Wilske B; Schierz G; Preac-Mursic V; Weber K; Pfister HW; Einhäupl K
Infection; 1984; 12(5):331-7. PubMed ID: 6392104
[TBL] [Abstract][Full Text] [Related]
34. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor.
Benach JL; Fleit HB; Habicht GS; Coleman JL; Bosler EM; Lane BP
J Infect Dis; 1984 Oct; 150(4):497-507. PubMed ID: 6386995
[TBL] [Abstract][Full Text] [Related]
35. Variation in a major surface protein of Lyme disease spirochetes.
Barbour AG; Tessier SL; Hayes SF
Infect Immun; 1984 Jul; 45(1):94-100. PubMed ID: 6735474
[TBL] [Abstract][Full Text] [Related]
36. Spirochetal Lipoproteins in Pathogenesis and Immunity.
Haake DA; Zückert WR
Curr Top Microbiol Immunol; 2018; 415():239-271. PubMed ID: 29196824
[TBL] [Abstract][Full Text] [Related]
37. An adsorption procedure to increase the specificity of enzyme-linked immunosorbent assays for Lyme disease without decreasing sensitivity.
Fawcett PT; O'Brien AE; Doughty RA
Arthritis Rheum; 1989 Aug; 32(8):1041-4. PubMed ID: 2669768
[TBL] [Abstract][Full Text] [Related]
38. Cellular immune findings in Lyme disease.
Sigal LH; Moffat CM; Steere AC; Dwyer JM
Yale J Biol Med; 1984; 57(4):595-8. PubMed ID: 6240164
[TBL] [Abstract][Full Text] [Related]
39. The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome).
Pfister HW; Einhäupl K; Preac-Mursic V; Wilske B; Schierz G
J Neurol; 1984; 231(3):141-4. PubMed ID: 6481420
[TBL] [Abstract][Full Text] [Related]
40. Major antigens of human oral spirochetes associated with periodontal disease.
Umemoto T; Zambon JJ; Genco RJ; Namikawa I
Adv Dent Res; 1988 Nov; 2(2):292-6. PubMed ID: 3271024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
